Zero Candida is on track to complete clinical trials and file for FDA approval in 2024 with its innovative technology.
Zero Candida’s SMART vaginal diagnostic device utilizes blue light therapy to treat this widespread condition without drugs. This non-drug therapy addresses key issues associated with conventional antifungal medications, including reduced risk of drug resistance, minimized side effects, and potential for faster symptom relief
This Zero Candida profile is part of a paid investor education campaign.*
Leave a Reply